Tuesday, July 14, 2026

DA-1726: The New Dual-Action Obesity Treatment Set to Transform Weight Loss in 2026

MetaVia's DA-1726 obesity treatment trial approved by U.S. IRB, focusing on dual-action GLP-1 and Glucagon receptors for weight loss.

WALLS WITHIN WALLS : Deciphering The Strategic Growth Of North Korea’s “Re-education” Map

North Korea is expanding prison facilities, indicating increased detention capacity and management, as seen in recent satellite imagery.

NVIDIA’s Stock Jumps 3% on News of New Partnership with Hewlett-Packard

NVIDIA's stock rose 3% after Hewlett-Packard launched a product with its new AI chip, Blackwell, easing previous release concerns.

Tag: VIP screening

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.